Thrombosis

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin


Publishing date
15 Nov 2011
Status
Published
Submission deadline
15 May 2011

1Laboratoire d'Hématologie, Université Victor Segalen, Bordeaux 2, 146 Rue LéoSaignat, 33076 Bordeaux Cedex, France

2Department of Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, 2160 First Avenue, Maywood, IL 60153, USA

3Department of Thoracic and Cardiovascular Surgery and Pathology, Cardiovascular Institute, Loyola University Medical Center, 2160 First Avenue, Maywood, IL 60153, USA

4Service de Neurology, CHU Pellegrin, Pêle des Neurosciences Cliniques, Université Victor Segalen, Bordeaux 2, 146 Rue LéoSaignat, 33076 Bordeaux Cedex, France

5Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK


Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin

Description

Aspirin is a well-known antiaggregative agent used in human at doses varying from 50 to 500 mg/day to prevent arterial thrombosis, cerebral stroke, or myocardial infarction and to reduce the risk of death in these patients. However, aspirin withdrawal may temporarily increase this risk. Dose selectivity of ASA towards platelet and vascular cyclooxygenase raised the question to know what dose is to be used to enhance its beneficial therapeutic effect.

We invite investigators to contribute original articles, review articles, case reports, and clinical studies related to all aspects of thrombosis and aspirin. Potential topics include, but are not limited to:

  • Clinical aspect
  • Aspirin in cardiology
  • Aspirin in neurology
  • Pharmacology of aspirin

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/thromb/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 626289
  • - Editorial

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin

Christian Doutremepuich
  • Special Issue
  • - Volume 2012
  • - Article ID 104707
  • - Research Article

Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations

Gundu H. R. Rao | Jawad Fareed
  • Special Issue
  • - Volume 2012
  • - Article ID 987932
  • - Clinical Study

The Role of Dermcidin Isoform 2: A Two-Faceted Atherosclerotic Risk Factor for Coronary Artery Disease and the Effect of Acetyl Salicylic Acid on It

Rajeshwary Ghosh | Uttam K. Maji | ... | Asru K. Sinha
  • Special Issue
  • - Volume 2012
  • - Article ID 676237
  • - Research Article

Paradoxical Effect of Aspirin

Christian Doutremepuich | Omar Aguejouf | ... | Francisco X. Eizayaga
  • Special Issue
  • - Volume 2012
  • - Article ID 376721
  • - Review Article

Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms

Bianca Rocca | Giovanna Petrucci
  • Special Issue
  • - Volume 2012
  • - Article ID 247363
  • - Review Article

Thrombotic Events Associated to Aspirin Therapy

Christian Doutremepuich | Omar Aguejouf | ... | Francisco X. Eizayaga
  • Special Issue
  • - Volume 2012
  • - Article ID 245037
  • - Review Article

Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease

Yuxiang Dai | Junbo Ge
  • Special Issue
  • - Volume 2012
  • - Article ID 173124
  • - Review Article

Aspirin: Pharmacology and Clinical Applications

Enma V. Paez Espinosa | John P. Murad | Fadi T. Khasawneh
  • Special Issue
  • - Volume 2012
  • - Article ID 430460
  • - Review Article

Beneficial Effect of Ultra-Low-Dose Aspirin in Platelet Activity Alterations and Haemorrhage Observed in Experimental Portal Hypertension

F. X. Eizayaga | O. Aguejouf | ... | C. Doutremepuich
  • Special Issue
  • - Volume 2012
  • - Article ID 720254
  • - Review Article

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?

Wolfgang Lösche | Janina Boettel | ... | Michael Bauer

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.